Stock Market News in real time

Progression-Free Survival 16.6 Months For Opdivo/Cabometyx Vs 8.3 Months For Sunitinib -Phase Iii Study

September 18, 2020 at 06:05 pm EDT

PROGRESSION-FREE SURVIVAL 16.6 MONTHS FOR OPDIVO/CABOMETYX VS 8.3 MONTHS FOR SUNITINIB -PHASE III STUDY

Weekly market update: Is the market in perfect harmony?

Arm Holdings plans to launch AI chips in 2025, Nikkei reports

Oil plant in Russia's Bashkortostan stopped its cat cracker after drone attack 9 May, sources say

Billionaire investor Ken Griffin calls on Harvard to embrace 'western values'

Biden jokes Trump should have injected himself with bleach

Wall Street closes up ahead of inflation data

May 10, 2024 at 06:17 pm EDT

US to hold auctions to sell airline warrants received during COVID bailouts

Wall Street: initial gains erased but positive week

News Highlights : Top Global Markets News of the Day - Friday at 5 PM ET

News Highlights : Top Global Markets News of the Day - Friday at 7 PM ET